As drugmakers navigate an increasingly complex terrain of scientific and digital influence, the ability to accurately identify and understand both key and digital opinion leaders is vital for effective engagement.
Esther Van Hulten
Advertisement
VP and GM, Global Reference Info & Digital, IQVIA
Articles by Esther Van Hulten
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
3
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
4
Study Claims Ozempic Lowers Biological Age
5
